Fry and Sons

Fry Laboratories is a specialized clinical diagnostic laboratory focused on the molecular detection of chronic infectious diseases and vector-borne pathogens. The company utilizes advanced technologies, including next-generation sequencing (NGS) and its proprietary RiboSeq platform, to identify complex microbial communities and biofilms that often evade traditional testing methods. Their services are primarily utilized by clinicians investigating persistent or unexplained illnesses such as Lyme disease, bartonellosis, and other systemic infections. By providing high-sensitivity molecular analysis, Fry Laboratories aims to improve the diagnostic accuracy for patients suffering from chronic inflammatory and infectious conditions.